Ra Medical Systems, Inc

Compare this stock

RMED Stock Report Card

Today's performance

27%

Performance

Score:

10/100

RMED returned -95.79% in the last 12 months. Based on SPY's performance of -8.73%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

Score:

75/100

4 analysts offer 12-month price targets for RMED. Together, they have an average target of 0, the most optimistic target put RMED at 0 within 12-months and the most pessimistic has RMED at 0. These analyst ratings are from our partners at Financial Modeling Prep (https://site.financialmodelingprep.com/) and Alpha Vantage (https://www.alphavantage.co/).

Technicals

Score:

11/100

RMED receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Earnings

Score:

10/100

RMED has missed earnings 12 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 20 quarters, RMED has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

Score:

44/100

RMED has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

Ra Medical Systems, Inc Summary

Healthcare

Medical Devices

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Power up your portfolio